National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
D026683:Advisory Committees; D002986:Clinical Trials as Topic; D004274:DNA, Recombinant; D030881:Disclosure; D026724:Ethical Review; D028744:Ethics Committees, Research; D035082:Federal Government; D005818:Genetic Engineering; D033161:Government Regulation; D006801:Humans; D033181:Information Dissemination; D007258:Informed Consent; D009316:National Institutes of Health (U.S.); D018579:Patient Selection; D012107:Research Design; D035842:Research Subjects; D018570:Risk Assessment; D014481:United States
D004274:DNA, Recombinant